Biosynexus Incorporated Employee Directory

Biotechnology ResearchUnited States2-10 Employees

Biosynexus Incorporated is a United States–based biotechnology research company focused on developing antibody and enzymatic therapies to prevent and treat bacterial infections. Its lead program targets staphylococcal sepsis in very low birth weight infants within NICU settings, aiming to reduce infection risk in a highly vulnerable patient population. Additional candidates include lysostaphin for serious staphylococcal infections and nisin formulated as a topical cream for treating serious skin infections, reflecting a broader emphasis on combating bacterial threats. The company operates within the biopharmaceutical sector, seeking to bring preventive and therapeutic products to market in coordination with clinical needs in neonatal and infection-related care. Biosynexus positions itself as a focused developer of solutions for bacterial infections, particularly those affecting newborns, with operations based in the United States and a small organizational footprint.

Sign up for free to view info

Company overview Email format